Opportunities and challenges to the use of neutralizing monoclonal antibody therapies for COVID-19

J Su, H Lu - BioScience Trends, 2021 - jstage.jst.go.jp
The coronavirus disease 2019 (COVID-19) pandemic has resulted in a substantial global
public healthcare crisis, leading to the urgent need for effective therapeutic strategies …
被引用次数：8 相关文章

Opportunities and challenges to the use of neutralizing monoclonal antibody therapies for COVID-19

S Jie, L Hongzhou - BioScience Trends, 2021 - cir.nii.ac.jp
抄録< p> The coronavirus disease 2019 (COVID-19) pandemic has resulted in a substantial
global public healthcare crisis, leading to the urgent need for effective therapeutic strategies …

Opportunities and challenges to the use of neutralizing monoclonal antibody therapies for COVID-19.

J Su, H Lu - Bioscience Trends, 2021 - europepmc.org
The coronavirus disease 2019 (COVID-19) pandemic has resulted in a substantial global
public healthcare crisis, leading to the urgent need for effective therapeutic strategies …

Opportunities and challenges to the use of neutralizing monoclonal antibody therapies for COVID-19

J Su, H Lu - Bioscience trends, 2021 - pubmed.ncbi.nlm.nih.gov
The coronavirus disease 2019 (COVID-19) pandemic has resulted in a substantial global
public healthcare crisis, leading to the urgent need for effective therapeutic strategies …

Opportunities and challenges to the use of neutralizing monoclonal antibody therapies for COVID-19

J Su, H Lu - BioScience Trends, 2021 - jstage.jst.go.jp
The coronavirus disease 2019 (COVID-19) pandemic has resulted in a substantial global
public healthcare crisis, leading to the urgent need for effective therapeutic strategies …
[PDF] archive.org

[PDF][PDF] Opportunities and challenges to the use of neutralizing monoclonal antibody therapies for COVID-19

J Su, H Lu - scholar.archive.org
The coronavirus disease 2019 (COVID-19) pandemic has resulted in a substantial global
public healthcare crisis, leading to the urgent need for effective therapeutic strategies …

Opportunities and challenges to the use of neutralizing monoclonal antibody therapies for COVID-19.

J Su, H Lu - BioScience Trends, 2021 - search.ebscohost.com
Abstract The coronavirus disease 2019 (COVID-19) pandemic has resulted in a substantial
global public healthcare crisis, leading to the urgent need for effective therapeutic strategies …